67 related articles for article (PubMed ID: 38481255)
1. Antiangiogenic therapy for high-grade glioma.
Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy, lymphopenia and improving the outcome for glioblastoma: a narrative review.
Kut C; Kleinberg L
Chin Clin Oncol; 2023 Feb; 12(1):4. PubMed ID: 36922353
[TBL] [Abstract][Full Text] [Related]
3. Systematic review and pooled analysis of the impact of treatment-induced lymphopenia on survival of glioblastoma patients.
Saeed AM; Bentzen SM; Ahmad H; Pham L; Woodworth GF; Mishra MV
Radiat Oncol; 2024 Mar; 19(1):36. PubMed ID: 38481255
[TBL] [Abstract][Full Text] [Related]
4. Anti-angiogenic therapy for high-grade glioma.
Ameratunga M; Pavlakis N; Wheeler H; Grant R; Simes J; Khasraw M
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008218. PubMed ID: 30480778
[TBL] [Abstract][Full Text] [Related]
5. Association between treatment-related lymphopenia and survival in glioblastoma patients following postoperative chemoradiotherapy.
Mapelli R; Julita C; Bianchi SP; Gallina N; Lucchini R; Midulla M; Puci F; Saddi J; Trivellato S; Panizza D; De Ponti E; Arcangeli S
Strahlenther Onkol; 2022 May; 198(5):448-457. PubMed ID: 34617129
[TBL] [Abstract][Full Text] [Related]
6. Effect of Radiation Treatment Volume Reduction on Lymphopenia in Patients Receiving Chemoradiotherapy for Glioblastoma.
Rudra S; Hui C; Rao YJ; Samson P; Lin AJ; Chang X; Tsien C; Fergus S; Mullen D; Yang D; Thotala D; Hallahan D; Campian JL; Huang J
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):217-225. PubMed ID: 29502931
[TBL] [Abstract][Full Text] [Related]
7. Association between treatment-related lymphopenia and overall survival in elderly patients with newly diagnosed glioblastoma.
Mendez JS; Govindan A; Leong J; Gao F; Huang J; Campian JL
J Neurooncol; 2016 Apr; 127(2):329-35. PubMed ID: 26725885
[TBL] [Abstract][Full Text] [Related]
8. Clinical predictors of radiation-induced lymphopenia in patients receiving chemoradiation for glioblastoma: clinical usefulness of intensity-modulated radiotherapy in the immuno-oncology era.
Byun HK; Kim N; Yoon HI; Kang SG; Kim SH; Cho J; Baek JG; Chang JH; Suh CO
Radiat Oncol; 2019 Mar; 14(1):51. PubMed ID: 30917849
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy for Glioblastoma: Current Progress and Challenges.
Yu MW; Quail DF
Front Immunol; 2021; 12():676301. PubMed ID: 34054867
[TBL] [Abstract][Full Text] [Related]
10. Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons.
Mohan R; Liu AY; Brown PD; Mahajan A; Dinh J; Chung C; McAvoy S; McAleer MF; Lin SH; Li J; Ghia AJ; Zhu C; Sulman EP; de Groot JF; Heimberger AB; McGovern SL; Grassberger C; Shih H; Ellsworth S; Grosshans DR
Neuro Oncol; 2021 Feb; 23(2):284-294. PubMed ID: 32750703
[TBL] [Abstract][Full Text] [Related]
11. Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma: The CheckMate 143 Phase 3 Randomized Clinical Trial.
Reardon DA; Brandes AA; Omuro A; Mulholland P; Lim M; Wick A; Baehring J; Ahluwalia MS; Roth P; Bähr O; Phuphanich S; Sepulveda JM; De Souza P; Sahebjam S; Carleton M; Tatsuoka K; Taitt C; Zwirtes R; Sampson J; Weller M
JAMA Oncol; 2020 Jul; 6(7):1003-1010. PubMed ID: 32437507
[TBL] [Abstract][Full Text] [Related]
12. Steroids use and survival in patients with glioblastoma multiforme: a pooled analysis.
Petrelli F; De Stefani A; Ghidini A; Bruschieri L; Riboldi V; Dottorini L; Iaculli A; Zaniboni A; Trevisan F
J Neurol; 2021 Feb; 268(2):440-447. PubMed ID: 32002651
[TBL] [Abstract][Full Text] [Related]
13. The association between total lymphocyte count after concomitant chemoradiation and overall survival in patients with newly diagnosed glioblastoma.
Ahn S; Park JS; Jang J; Ahn KJ; Hong YK; Yang SH; Jeun SS
J Clin Neurosci; 2020 Jan; 71():21-25. PubMed ID: 31843432
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy, Lymphopenia, and Host Immune Capacity in Glioblastoma: A Potentially Actionable Toxicity Associated With Reduced Efficacy of Radiotherapy.
Kleinberg L; Sloan L; Grossman S; Lim M
Neurosurgery; 2019 Oct; 85(4):441-453. PubMed ID: 31232425
[TBL] [Abstract][Full Text] [Related]
15. Dosimetry of the brain and hypothalamus predicting acute lymphopenia and the survival of glioma patients with postoperative radiotherapy.
Ye LL; Fan XW; Hu CS; He XY; Wang XS; Shen CY; Xu TT; Ying HM
Cancer Med; 2019 Jun; 8(6):2759-2768. PubMed ID: 30983159
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
